Triglyceride lowering in patients with different severities of hypertriglyceridaemia-associated acute pancreatitis: secondary analysis of a multicentre, prospective cohort study

Objective It is controversial whether rapid lowering of triglyceride (TG) levels is associated with clinical benefits in patients with hypertriglyceridaemia-associated acute pancreatitis (HTG-AP). In particular, patients with different severity of disease may respond differently to TG-lowering thera...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaoling Li, Lin Gao, Xiang Luo, Wenjian Mao, Lu Ke, Xiaoyan Lai, Lingyan Fu, Yaolu Liu
Format: Article
Language:English
Published: BMJ Publishing Group 2025-01-01
Series:BMJ Open Gastroenterology
Online Access:https://bmjopengastro.bmj.com/content/12/1/e001620.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832590887369048064
author Xiaoling Li
Lin Gao
Xiang Luo
Wenjian Mao
Lu Ke
Xiaoyan Lai
Lingyan Fu
Yaolu Liu
author_facet Xiaoling Li
Lin Gao
Xiang Luo
Wenjian Mao
Lu Ke
Xiaoyan Lai
Lingyan Fu
Yaolu Liu
author_sort Xiaoling Li
collection DOAJ
description Objective It is controversial whether rapid lowering of triglyceride (TG) levels is associated with clinical benefits in patients with hypertriglyceridaemia-associated acute pancreatitis (HTG-AP). In particular, patients with different severity of disease may respond differently to TG-lowering therapy. In this study, we aimed to explore the association between rapid decline in serum TG levels and organ failure in patients with different severities of HTG-AP.Methods This is a secondary analysis of data from a multicentre, prospective registry recruiting HTG-AP patients admitted within 72 hours from the onset of symptoms. Patients were dichotomised into either target reaching (TG≤5.65 mmol/L on study day 3) or not. The primary outcome was the presence of organ failure at day 14. The association between target-reaching and the primary outcome was modelled. Furthermore, subgroup analyses were conducted based on the disease severity of HTG-AP patients at enrolment.Results Overall, 413 patients were included for analysis, of whom 192 (46.5%) reached the target on day 3. For the overall study cohort, there was no significant difference in presence of organ failure at day 14 between patients reaching the target or not (3.1% vs 6.8%, p=0.091). In the subgroup of HTG-AP patients with organ failure at enrolment, compared with patients with TG>5.65 mmol/L on day 3, patients who reached the target had significantly lower presence of organ failure at day 14 (7.8% vs 22%, p=0.039) and lower incidence of infected pancreatic necrosis within 60 days (3.1% vs 11.9%, p=0.049). Similar findings were seen in the subgroup with more severe HTG-AP (APACHE II ≥8 at enrolment).Conclusion More rapid decline of serum TG levels was associated with decreased presence of organ failure at day 14 in patients with more severe HTG-AP.Trial registration number The Chinese Clinical Trial Registry, number ChiCTR2000039541.
format Article
id doaj-art-6dc4e16bb4ba4778b600f8cca1ec2d5d
institution Kabale University
issn 2054-4774
language English
publishDate 2025-01-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open Gastroenterology
spelling doaj-art-6dc4e16bb4ba4778b600f8cca1ec2d5d2025-01-23T05:40:09ZengBMJ Publishing GroupBMJ Open Gastroenterology2054-47742025-01-0112110.1136/bmjgast-2024-001620Triglyceride lowering in patients with different severities of hypertriglyceridaemia-associated acute pancreatitis: secondary analysis of a multicentre, prospective cohort studyXiaoling Li0Lin Gao1Xiang Luo2Wenjian Mao3Lu Ke4Xiaoyan Lai5Lingyan Fu6Yaolu Liu7Department of Anesthesiology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, Fujian, ChinaDepartment of Critical Care Medicine, Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, ChinaDepartment of Critical Care Medicine, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, Fujian, ChinaDepartment of Critical Care Medicine, Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, ChinaDepartment of Critical Care Medicine, Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, ChinaDepartment of Critical Care Medicine, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, Fujian, ChinaDepartment of Critical Care Medicine, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, Fujian, ChinaDepartment of Critical Care Medicine, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, Fujian, ChinaObjective It is controversial whether rapid lowering of triglyceride (TG) levels is associated with clinical benefits in patients with hypertriglyceridaemia-associated acute pancreatitis (HTG-AP). In particular, patients with different severity of disease may respond differently to TG-lowering therapy. In this study, we aimed to explore the association between rapid decline in serum TG levels and organ failure in patients with different severities of HTG-AP.Methods This is a secondary analysis of data from a multicentre, prospective registry recruiting HTG-AP patients admitted within 72 hours from the onset of symptoms. Patients were dichotomised into either target reaching (TG≤5.65 mmol/L on study day 3) or not. The primary outcome was the presence of organ failure at day 14. The association between target-reaching and the primary outcome was modelled. Furthermore, subgroup analyses were conducted based on the disease severity of HTG-AP patients at enrolment.Results Overall, 413 patients were included for analysis, of whom 192 (46.5%) reached the target on day 3. For the overall study cohort, there was no significant difference in presence of organ failure at day 14 between patients reaching the target or not (3.1% vs 6.8%, p=0.091). In the subgroup of HTG-AP patients with organ failure at enrolment, compared with patients with TG>5.65 mmol/L on day 3, patients who reached the target had significantly lower presence of organ failure at day 14 (7.8% vs 22%, p=0.039) and lower incidence of infected pancreatic necrosis within 60 days (3.1% vs 11.9%, p=0.049). Similar findings were seen in the subgroup with more severe HTG-AP (APACHE II ≥8 at enrolment).Conclusion More rapid decline of serum TG levels was associated with decreased presence of organ failure at day 14 in patients with more severe HTG-AP.Trial registration number The Chinese Clinical Trial Registry, number ChiCTR2000039541.https://bmjopengastro.bmj.com/content/12/1/e001620.full
spellingShingle Xiaoling Li
Lin Gao
Xiang Luo
Wenjian Mao
Lu Ke
Xiaoyan Lai
Lingyan Fu
Yaolu Liu
Triglyceride lowering in patients with different severities of hypertriglyceridaemia-associated acute pancreatitis: secondary analysis of a multicentre, prospective cohort study
BMJ Open Gastroenterology
title Triglyceride lowering in patients with different severities of hypertriglyceridaemia-associated acute pancreatitis: secondary analysis of a multicentre, prospective cohort study
title_full Triglyceride lowering in patients with different severities of hypertriglyceridaemia-associated acute pancreatitis: secondary analysis of a multicentre, prospective cohort study
title_fullStr Triglyceride lowering in patients with different severities of hypertriglyceridaemia-associated acute pancreatitis: secondary analysis of a multicentre, prospective cohort study
title_full_unstemmed Triglyceride lowering in patients with different severities of hypertriglyceridaemia-associated acute pancreatitis: secondary analysis of a multicentre, prospective cohort study
title_short Triglyceride lowering in patients with different severities of hypertriglyceridaemia-associated acute pancreatitis: secondary analysis of a multicentre, prospective cohort study
title_sort triglyceride lowering in patients with different severities of hypertriglyceridaemia associated acute pancreatitis secondary analysis of a multicentre prospective cohort study
url https://bmjopengastro.bmj.com/content/12/1/e001620.full
work_keys_str_mv AT xiaolingli triglycerideloweringinpatientswithdifferentseveritiesofhypertriglyceridaemiaassociatedacutepancreatitissecondaryanalysisofamulticentreprospectivecohortstudy
AT lingao triglycerideloweringinpatientswithdifferentseveritiesofhypertriglyceridaemiaassociatedacutepancreatitissecondaryanalysisofamulticentreprospectivecohortstudy
AT xiangluo triglycerideloweringinpatientswithdifferentseveritiesofhypertriglyceridaemiaassociatedacutepancreatitissecondaryanalysisofamulticentreprospectivecohortstudy
AT wenjianmao triglycerideloweringinpatientswithdifferentseveritiesofhypertriglyceridaemiaassociatedacutepancreatitissecondaryanalysisofamulticentreprospectivecohortstudy
AT luke triglycerideloweringinpatientswithdifferentseveritiesofhypertriglyceridaemiaassociatedacutepancreatitissecondaryanalysisofamulticentreprospectivecohortstudy
AT xiaoyanlai triglycerideloweringinpatientswithdifferentseveritiesofhypertriglyceridaemiaassociatedacutepancreatitissecondaryanalysisofamulticentreprospectivecohortstudy
AT lingyanfu triglycerideloweringinpatientswithdifferentseveritiesofhypertriglyceridaemiaassociatedacutepancreatitissecondaryanalysisofamulticentreprospectivecohortstudy
AT yaoluliu triglycerideloweringinpatientswithdifferentseveritiesofhypertriglyceridaemiaassociatedacutepancreatitissecondaryanalysisofamulticentreprospectivecohortstudy